image
Healthcare - Biotechnology - NASDAQ - US
$ 1.1365
-7.44 %
$ 45.8 M
Market Cap
-1.1
P/E
BALANCE SHEET
142 M ASSETS
-26.33%
15.6 M LIABILITIES
-30.26%
126 M EQUITY
-25.82%
BALANCE SHEET DECOMPOSITION
Balance Sheet Ikena Oncology, Inc.
image
Current Assets 127 M
Cash & Short-Term Investments 124 M
Receivables 0
Other Current Assets 2.78 M
Non-Current Assets 14.3 M
Long-Term Investments 0
PP&E 4.23 M
Other Non-Current Assets 10.1 M
87.90 %2.99 %7.15 %Total Assets$141.5m
Current Liabilities 10.8 M
Accounts Payable 897 K
Short-Term Debt 3.78 M
Other Current Liabilities 6.1 M
Non-Current Liabilities 4.8 M
Long-Term Debt 0
Other Non-Current Liabilities 4.8 M
5.76 %24.29 %39.14 %30.80 %Total Liabilities$15.6m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018
ASSETS
Cash & Cash Equivalents 39.4 119.9 59.9 232.2 162.5 82.1 18.2
Short Term Investments 85.0 55.6 97.0 0 0 0 0
Receivables 0 0 0 0 0 0 0
Inventory 0 0 0 0 0 0 0
Other Current Assets 2.8 3.2 3.1 4.3 3.5 3.1 1.8
Total Current Assets 127.2 178.7 160.0 236.5 166.0 85.2 20.0
PP&E 4.2 8.0 8.5 9.0 1.6 0.8 0.7
Intangible Assets 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0
Long Term Investments 0 0 0.9 2.4 0.9 0 0
Other Long Term Assets 10.1 5.4 2.9 0 0 (0.8) 1
Other Assets 0 0 0 0 0 0 1
Total Assets 141.5 192.1 172.3 247.9 168.4 86.0 20.7
LIABILITIES
Accounts Payable 0.9 2.1 2.1 2.4 2.1 0.9 2.3
Short Term Debt 3.8 3.6 3.8 3.7 (17.6) 0 0
Other Current Liabilities 6.1 8.6 6.4 4.0 5.0 2.6 1.6
Total Current Liabilities 10.8 14.2 21.5 27.2 28.3 24.3 3.8
Long Term Debt 0 7.2 3.8 5.1 0 78.9 62.6
Deferred Tax Income 0 0 0 (7.7) (206.0) (78.9) 0
Other Liabilities 4.8 0.9 0 0 206.0 0 0
Total Liabilities 15.6 22.3 25.3 40.0 269.5 147.4 66.5
EQUITY
Common Stock 48 K 48 K 36 K 36 K 3 K 3 K 19 K
Retained Earnings (331.6) (282.4) (214.2) (145.5) (111.3) (67.1) (50.3)
Other Accumulative Comprehensive Income/Loss 68 K 48 K (0.8) (247.9) (206.0) (78.9) 0
Total Equity 125.9 169.8 147.0 207.9 (101.0) (61.5) (45.8)
Total Liabilities and Equity 141.5 192.1 172.3 247.9 168.4 86.0 20.7
SHARES OUTSTANDING
Common Shares Outstanding 48.3 41.7 36.2 36.0 35.9 35.9 35.9